chemocentryx inc (CCXI:NASDAQ GS)
Thomas J. Schall Ph.D.
Founder, Chairman, Chief Executive Officer and President, ChemoCentryx, Inc.
|Age||Total Calculated Compensation||This person is connected to 16 board members in 1 different organizations across 1 different industries.|
See Board Relationships
As of Fiscal Year 2013
Dr. Thomas J. Schall, Ph.D. founded ChemoCentryx Inc. in November 1996 and has been its Chief Executive Officer and President since November 1996. Dr. Schall focuses on the discovery and development of chemokine-based therapeutics widely regarded as a Leader in chemokine research, his laboratories have been responsible for the discovery or co-discovery of almost one-third of all known chemokine receptors. From December 1993 to November 1996, he worked at the DNAX ResearchInstitute, ...
850 Maude AvenuePhone: 650-210-2900
Mountain View, California 94043
Board Members Memberships*
Founder, Chairman, Chief Executive Officer and President
The Leland Stanford Junior University
Northern Illinois University
|Lamberto Andreotti||Chief Executive Officer, Director, Member of Executive Committee and Member of Securities Issuance Committee|
Bristol-Myers Squibb Company
|George A. Scangos Ph.D.||Chief Executive Officer and Director|
Biogen Idec Inc.
|Erez Vigodman||Chief Executive Officer, President, Director, Member of Audit Committee and Member of Finance & Invesment Committee|
Teva Pharmaceutical Industries Limited
|Herve Hoppenot||Chief Executive Officer, President and Director|
|Yasuchika Hasegawa||Chairman of the Board and Chief Executive Officer|
Takeda Pharmaceutical Company Limited
|--||Compensation as of Fiscal Year 2013.|